Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis
S Huang, S Ong, D McKenzie, A Mirabelli… - Prostate Cancer and …, 2023 - nature.com
Background Prostate-specific membrane antigen (PSMA) positron emission tomography
(PET)/computed tomography (CT) has become an increasingly established imaging …
(PET)/computed tomography (CT) has become an increasingly established imaging …
[HTML][HTML] Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives
M Bauckneht, C Ciccarese, R Laudicella… - Cancer Treatment …, 2024 - Elsevier
In the last years, theranostics has expanded the therapeutic options available for prostate
cancer patients. In this review, we explore this dynamic field and its potential to revolutionize …
cancer patients. In this review, we explore this dynamic field and its potential to revolutionize …
Higher preoperative maximum standardised uptake values (SUVmax) are associated with higher biochemical recurrence rates after robot-assisted radical …
This study aimed to investigate the association between the 68Ga-or 18F-radiolabeled
prostate-specific membrane antigen (PSMA) tracer expression, represented by the …
prostate-specific membrane antigen (PSMA) tracer expression, represented by the …
Impact of Circulating Tumor Cell–Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate Cancer
H Cho, SS Byun, NH Son, JI Chung, WI Seo… - Clinical Cancer …, 2024 - AACR
Purpose: Prostate-specific membrane antigen (PSMA)–based images, which visually
quantify PSMA expression, are used to determine prostate cancer micrometastases. This …
quantify PSMA expression, are used to determine prostate cancer micrometastases. This …
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value
S Bela Andela, H Amthauer, C Furth, JM Rogasch… - Radiation …, 2024 - Springer
Background PSMA-PET is increasingly used for staging prostate cancer (PCA) patients.
However, it is not clear if quantitative imaging parameters of positron emission tomography …
However, it is not clear if quantitative imaging parameters of positron emission tomography …
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics
MJ Roberts, N Papa, H Veerman, K de Bie… - BJU …, 2024 - Wiley Online Library
Objectives To construct and externally calibrate a predictive model for early biochemical
recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern …
recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern …
PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC)
I Henríquez, B Malave, FL Campos, EC Hidalgo… - Clinical and …, 2024 - Springer
Background Metastatic hormone-sensitive prostate cancer (mHSPC) is treatment-resistant
and generally considered incurable. The development of prostate-specific membrane …
and generally considered incurable. The development of prostate-specific membrane …
Clinical utility of [68Ga] Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values
I Rogic, AT Golubic, M Zuvic, T Smitran… - Nuclear Medicine …, 2024 - journals.viamedica.pl
Background: As in disease recurrence, providing clinicians with the exact extent of the
disease at the time of initial diagnosis is key in the management and individual treatment of …
disease at the time of initial diagnosis is key in the management and individual treatment of …
18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study
I Vierasu, G Van Simaeys, N Trotta, S Lacroix… - European journal of …, 2023 - Springer
Background Positron emission tomography/computed tomography (PET/CT) using
radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in …
radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in …
Quantitative [68Ga]Ga-PSMA-11 PET biomarkers for the analysis of lesion-level progression in biochemically recurrent prostate cancer: a multicentre study
J Kendrick, RJ Francis, GM Hassan… - Scientific Reports, 2023 - nature.com
Abstract [68Ga] Ga-PSMA-11 PET has become the standard imaging modality for
biochemically recurrent (BCR) prostate cancer (PCa). However, its prognostic value in …
biochemically recurrent (BCR) prostate cancer (PCa). However, its prognostic value in …